194 related articles for article (PubMed ID: 29389973)
1. Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen.
Bougaret L; Delort L; Billard H; Le Huede C; Boby C; De la Foye A; Rossary A; Mojallal A; Damour O; Auxenfans C; Vasson MP; Caldefie-Chezet F
PLoS One; 2018; 13(2):e0191571. PubMed ID: 29389973
[TBL] [Abstract][Full Text] [Related]
2. Supernatants of Adipocytes From Obese Versus Normal Weight Women and Breast Cancer Cells: In Vitro Impact on Angiogenesis.
Bougaret L; Delort L; Billard H; Lequeux C; Goncalves-Mendes N; Mojallal A; Damour O; Vasson MP; Caldefie-Chezet F
J Cell Physiol; 2017 Jul; 232(7):1808-1816. PubMed ID: 27886379
[TBL] [Abstract][Full Text] [Related]
3. Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin.
Delort L; Bougaret L; Cholet J; Vermerie M; Billard H; Decombat C; Bourgne C; Berger M; Dumontet C; Caldefie-Chezet F
Nutrients; 2019 Nov; 11(12):. PubMed ID: 31756890
[TBL] [Abstract][Full Text] [Related]
4. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
[TBL] [Abstract][Full Text] [Related]
5. Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.
Theriau CF; Sauvé OS; Beaudoin MS; Wright DC; Connor MK
PLoS One; 2017; 12(9):e0183897. PubMed ID: 28873415
[TBL] [Abstract][Full Text] [Related]
6. Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production.
Bowers LW; Brenner AJ; Hursting SD; Tekmal RR; deGraffenried LA
Breast Cancer Res Treat; 2015 Jan; 149(1):49-57. PubMed ID: 25476497
[TBL] [Abstract][Full Text] [Related]
7. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
8. Adipocytes contribute to the growth and progression of multiple myeloma: Unraveling obesity related differences in adipocyte signaling.
Bullwinkle EM; Parker MD; Bonan NF; Falkenberg LG; Davison SP; DeCicco-Skinner KL
Cancer Lett; 2016 Sep; 380(1):114-21. PubMed ID: 27317873
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
Chen JL; Chang CJ; Wang JY; Wen CS; Tseng LM; Chang WC; Noomhorm N; Liu HJ; Chen WS; Chiu JH; Shyr YM
Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the leptin receptors expression in breast cancer cell lines exposed to leptin and tamoxifen.
Linares RL; Benítez JGS; Reynoso MO; Romero CG; Sandoval-Cabrera A
Sci Rep; 2019 Dec; 9(1):19189. PubMed ID: 31844100
[TBL] [Abstract][Full Text] [Related]
12. Adipocytes secretome from normal and tumor breast favor breast cancer invasion by metabolic reprogramming.
Zaoui M; Morel M; Louadj L; Ferrand N; Lamazière A; Uzan C; Canlorbe G; Atlan M; Sabbah M
Clin Transl Oncol; 2023 May; 25(5):1389-1401. PubMed ID: 36520383
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.
Kim J; Lee J; Kim C; Choi J; Kim A
Tumour Biol; 2016 May; 37(5):5811-9. PubMed ID: 26581908
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
15. [Leptin: Involvement in the pathophysiology of breast cancer].
Caldefie-Chézet F; Dubois V; Delort L; Rossary A; Vasson MP
Ann Endocrinol (Paris); 2013 May; 74(2):90-101. PubMed ID: 23566612
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Endocrine Therapy Promotes Weight Gain With Distinct Adipose Tissue Effects in Lean and Obese Female Mice.
Scalzo RL; Foright RM; Hull SE; Knaub LA; Johnson-Murguia S; Kinanee F; Kaplan J; Houck JA; Johnson G; Sharp RR; Gillen AE; Jones KL; Zhang AMY; Johnson JD; MacLean PS; Reusch JEB; Wright-Hobart S; Wellberg EA
Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34410380
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update.
Chu DT; Phuong TNT; Tien NLB; Tran DK; Nguyen TT; Thanh VV; Quang TL; Minh LB; Pham VH; Ngoc VTN; Kushekhar K; Chu-Dinh T
Cells; 2019 Aug; 8(8):. PubMed ID: 31398937
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance.
Bekele RT; Venkatraman G; Liu RZ; Tang X; Mi S; Benesch MG; Mackey JR; Godbout R; Curtis JM; McMullen TP; Brindley DN
Sci Rep; 2016 Feb; 6():21164. PubMed ID: 26883574
[TBL] [Abstract][Full Text] [Related]
19. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
Papanikolaou V; Stefanou N; Dubos S; Papathanasiou I; Palianopoulou M; Valiakou V; Tsezou A
Cell Oncol (Dordr); 2015 Apr; 38(2):155-64. PubMed ID: 25539992
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.
Yao-Borengasser A; Monzavi-Karbassi B; Hedges RA; Rogers LJ; Kadlubar SA; Kieber-Emmons T
Oncol Rep; 2015 Jun; 33(6):2689-94. PubMed ID: 25823469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
